A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation-Reference-Cited by-同舟云学术

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation

Published:2019-06-11 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Eilard Malin Sternby^ORCID,Andersson Mats^ORCID,Naredi Peter^ORCID,Geronymakis Charalampos^ORCID,Lindnér Per,Cahlin Christian,Bennet William,Rizell Magnus^ORCID

Funder

Bayer HealthCare

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5760-8.pdf

Reference42 articles.

1. Mehta N, Heimbach J, Lee D, Dodge J, Harnois D, Burns J, Sanchez W, Roberts J, Yao F. Wait time of less than 6 and greater than 18 months predicts hepatocellular carcinoma recurrence after liver transplantation: proposing a wait time "sweet spot". Transplantation. 2017;101(9):2071–8.

2. Pommergaard H-C, Arendtsen Rostved A, Adam R, Thygesen LC, Salizzoni M, Gomez Bravo MA, Cherqui D, De Simone P, Boudjema K, Mazzaferro V, et al. Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European liver transplant registry. Transpl Int. 2018;5:531–9.

3. Kulik L, Heimbach JK, Zaiem F, Almasri J, Prokop LJ, Wang Z, Murad MH, Mohammed K. Therapies for patients WithHepatocellular carcinoma AwaitingLiver transplantation: a SystematicReview and meta-analysis. Hepatology. 2018;67(1):381–400.

4. Lai Q, Di Martino M, Lucatelli P, Mennini G. Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: only selection or biological effect? World J Gastroenterol. 2018;24(31):3469–71.

5. Agopian VG, Morshedi MM, McWilliams J, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Hiatt JR, et al. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients. Ann Surg. 2015;262(3):536–45 discussion 543-535.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrobium nobile active ingredient Dendrobin A against hepatocellular carcinoma via inhibiting nuclear factor kappa-B signaling;Biomedicine & Pharmacotherapy;2024-08

2. Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis;Cancers;2023-01-18

3. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation;Transplant International;2022-11-09

4. Neoadjuvant Therapy for Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2022-08

5. Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF / TKI and immunotherapy;Hepatology;2022-07-30